… patients with COVID-19, so that the therapeutic consequences are … to have been using
corticosteroid therapy for months now, … clinical studies suggest benefits in COVID-19 patients [6]. …

… reduction in mortality in COVID-19 patients by one-… therapeutic outcomes. In this review, we
discuss the potential role and safety of these agents in the management of severe COVID-19, …

… This review article provides insights into the basic aspects of monoclonal antibodies (mAbs)
for the therapy of COVID-19, as well as its advancement in terms of clinical trial and current …

… for the treatment of COVID-19 patients. These drugs and therapeutic agents include antiviral
… and most updated therapeutic drugs to prevent, control, and treat COVID-19 patients until …

… Covid-19 … in Coronavirus infected cells. Hence, recently developed potent PERK inhibitors
(GSK-PERK inhibitor) could also serve as potential therapeutics for controlling Covid 19 …

… therapeutic agent for covid management. In this review, a consolidated summary of the
therapeutic … along with an overview of effective management of post COVID-19 complications. …

… Two compounds, remdesivir, and dexamethasone have been so far shown to reduce
COVID-19–… therapeutic agents being considered for the treatment and management of COVID-19 …

… identify effective therapeutic modalities for the treatment of COVID-19. Medical therapeutics
under current investigation may ultimately provide effective early interventions for COVID-19; …

… The World Health Organization (WHO) has declared coronavirus disease 2019 (COVID-19) …
management [2]. Due to the severity and the spreading of COVID-19 (novel coronavirus …

… anti-coronavirus activities. We also discuss the lessons learned from COVID-19 and other
infectious diseases with regard to drug repurposing strategies, pan-coronavirus drug targets, …